| DASATINIB                                                                                                                                                                                                                                                          
  |  DASATINIB |  ATC L01EA02
  ANTINEOPLASTIC   PROTEIN KINASE INHIBITORS   TREATMENT OF CHRONIC MYELOID LEUKEMIA (CML) IN CHRONIC PHASE  |  ORAL | VD 2505 LITER PPB 96 PERCENT Cl 433 LITER / HOUR (EQN) HT 4 HOUR SOLUBILITY INSOLUBLE IN WATER  |  BCR-ABL ABL1   SRC FAMILY (SRC, LCK, YES, FYN)   C-KIT   EPHA2   PDGFR BETA PDB 2Y6O (CRYSTAL STRUCTURE OF EPHA4 KINASE DOMAIN IN COMPLEX WITH DASATINIB.) LIGAND CODE = 1N1  (link to the list of PDB complexes)   Download experimental 3D coordinates of 1N1 with added hydrogens  |   Platelet-derived growth factor receptor beta UNIPROT P09619 PDGFRB -- Tyrosine-protein kinase ABL1 UNIPROT P00519 ABL1  more at DrugCentral  | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com VigiAccess SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank  |